BSX Stock Price, Chart, Stats & News

Boston Scientific Corporation
Save
72.62B
Market cap
20.44x
Current P/E
14.29x
Forward P/E
BSX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.01% |
Operating margin | 19.78% |
Pretax margin | 16.86% |
Net margin | 14.40% |
Effective tax rate | 14.56% |
ROA | 6.62% |
ROE | 12.53% |
D/E | 0.51x |
Interest coverage ratio | 11.22x |
BSX valuation
P/E | 20.44x |
P/S | 5.11x |
P/B | 4.23x |
P/CF | 22.62x |
P/FCF | 28.31x |
P/OCF | 22.62x |
PEG | 9.58x |
EV multiple | 18.80x |
About
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.
Similar securities
Based on sector and market capitalization
Report issue











